Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Antibiotic resistance is currently one of the most significant threats to global public health and safety. And studies have found that over the next 25 years, 39 million people will die directly and 169 million indirectly due to antibiotic-resistant diseases. Consequently, the development of new types of antimicrobial drugs is urgently needed. Antimicrobial peptides (AMPs) constitute an essential component of the innate immune response in all organisms. They exhibit a distinctive mechanism of action that endows them with a broad spectrum of biological activities, including antimicrobial, antibiofilm, antiviral, and anti-inflammatory effects. However, AMPs also present certain limitations, such as cytotoxicity, susceptibility to protein hydrolysis, and poor pharmacokinetic properties, which have impeded their clinical application. The development of delivery systems can address these challenges by modifying AMP delivery and enabling precise, controlled release at the site of infection or disease. This review offers a comprehensive analysis of the mechanisms of action and biological advantages of AMPs. and systematically evaluate how emerging drug delivery systems, such as nanoparticles and hydrogels, enhance the stability and bioavailability of AMPs, discussing both their strengths and limitations. Moreover, unlike previous reviews, this review highlight the most recent clinically approved AMP-based drugs and those currently in development, emphasizing the key challenges in translating these drugs into clinical practice. With these perspectives, it is hoped that this review will provide some insights into overcoming translational barriers and advancing AMPs drugs into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Endogenous inducers, on the other hand, are signals generated by stressed, damaged, or dysfunctional tissues [81].”
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01867-1 · Cited by 3,791 · cited 1×
“Furthermore, studies have revealed that antibiotic-resistant bacterial diseases are projected to directly cause over 39 million deaths globally in the next 25 years and indirectly contribute to an additional 169 million fatalities [3].”
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · cited 1×
“It primarily governs the expression of key proinflammatory mediators such as TNF-α, IL-6, IL-1β, and inflammatory chemokines [92].”
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398 · cited 1×
“For instance, β-lactam antibiotics frequently struggle to effectively cross biological membranes due to their high molecular polarity and lack of specific targeting [63].”
The MAPK signalling pathways and colorectal cancer
Fang, J. Y., & Richardson, B. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70168-6 · Cited by 1,185 · cited 1×
“Activation of this pathway leads to the phosphorylation of JNK, p38, and ERK, thereby promoting inflammation [93].”
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183 · cited 1×
“The TLR signaling pathway, the NF-κB pathway, and the MAPK pathway are a few of the critical signaling pathways associated with the regulation of inflammatory signal transduction [89, 90].”
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555 · cited 2×
“Furthermore, it permeates these biofilms and kills S. aureus at a concentration of 51.2 μM and A. baumannii at 12.8 μM [64].”
InfluentialNF-κB: blending metabolism, immunity, and inflammation
Capece, D., Verzella, D., Flati, I., Arboretto, P., Cornice, J., & Franzoso, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.07.004 · Cited by 538 · cited 1×
“The TLR signaling pathway, the NF-κB pathway, and the MAPK pathway are a few of the critical signaling pathways associated with the regulation of inflammatory signal transduction [89, 90].”
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3329 · Cited by 258 · cited 1×
“Moreover, the AMPs CAP18 and CAP11 from the cathelicidin family not only possess LPS-binding activity but also inhibit inflammation by binding to the cell surface of CD14 and preventing LPS-cell interactions, an effect confirmed in a mouse model of endotoxic shock [88].”
Cited by
Hydrogel Nanoparticles in Drug Delivery: A Review
Kianfar, E., Kadhum, W. R., & Mahmoud, Z. H. (2025) · Intelligent Pharmacy · doi:10.1016/j.ipha.2025.11.002 · Cited by 8
Metadata
- Authors
- Zheng, S., Tu, Y., Li, B., Qu, G., Li, A., Peng, X., Li, S., & Shao, C.
- Venue
- Journal of Translational Medicine
- Published
- 2025-03-07
- Volume
- 23
- Issue
- 1
- Pages
- 292-292
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W4408239302
- Cited by
- 177
- References
- 10
- FWCI
- 82.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. https://app.cochat.ai/papers/10.1186/s12967-025-06321-9
- The paper
- Zheng, S., Tu, Y., Li, B., Qu, G., Li, A., Peng, X., Li, S., & Shao, C. (2025). Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. Journal of Translational Medicine. https://doi.org/10.1186/s12967-025-06321-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.